{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:09:03Z","timestamp":1766052543465,"version":"3.48.0"},"reference-count":60,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroSci"],"abstract":"<jats:p>Background: Innovative treatments for lung cancer patients have significantly improved their lives. Therefore, patients who develop brain metastases are more likely to require management of quality of life (QoL) by reducing pathological decline in brain function. New therapeutic strategies have allowed us to manage brain metastases, thanks to the ability to cross the blood\u2013brain barrier. Moreover, new molecules have been designed as adjuvants to standard treatments for the management of cancer patients with brain metastases. Methods: We implemented a descriptive, observational, retrospective study. Therefore, we consecutively collected the data of eighty-six (N\u2009 = \u200986) patients admitted to our department (April 2020\u2013April 2025) diagnosed with brain involvement in a thoracic neoplasm and treated with silibinin, in association with standard treatment. The main endpoint of our analysis is to define the safety profile of silibinin and to evaluate its eventual benefits in terms of QoL. Results: Silibinin was well tolerated (only one mild adverse event was reported); furthermore, patients taking silibinin had a good quality of life that was maintained over a long period of time, and in some cases, an improvement in neurological symptoms and overall patient well-being was also documented. Conclusions: Our study is the first collection of a large number of lung cancer patients with brain metastasis taking silibinin, which is very well tolerated and allows patients to maintain a good QoL.<\/jats:p>","DOI":"10.3390\/neurosci6040131","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:15:21Z","timestamp":1766049321000},"page":"131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Brain Metastatic Lung Cancer Patients: A Multitarget Therapeutic-Supportive Strategy with Anti-STAT3 Silibinin"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7625-7708","authenticated-orcid":false,"given":"Elisa","family":"Roca","sequence":"first","affiliation":[{"name":"Thoracic Oncology\u2014Lung Unit, Pederzoli P. Hospital, 37019 Peschiera del Garda, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2314-7000","authenticated-orcid":false,"given":"Elena","family":"Roca","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Istituto Ospedaliero Fondazione Poliambulanza, 25124 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1277-3986","authenticated-orcid":false,"given":"Alessandra","family":"Cucinella","sequence":"additional","affiliation":[{"name":"Thoracic Oncology\u2014Lung Unit, Pederzoli P. Hospital, 37019 Peschiera del Garda, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4648-7646","authenticated-orcid":false,"given":"Giorgio","family":"Madonia","sequence":"additional","affiliation":[{"name":"Thoracic Oncology\u2014Lung Unit, Pederzoli P. Hospital, 37019 Peschiera del Garda, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Centonze","sequence":"additional","affiliation":[{"name":"Food Safety and Nutrition Service\u2014S.I.A.N., Department of Prevention, Azienda Sanitaria Locale ASL CN2, 12051 Alba-Bra, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorella","family":"Lombardo","sequence":"additional","affiliation":[{"name":"Thoracic Oncology\u2014Lung Unit, Pederzoli P. Hospital, 37019 Peschiera del Garda, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licia","family":"Martinelli","sequence":"additional","affiliation":[{"name":"Thoracic Oncology\u2014Lung Unit, Pederzoli P. Hospital, 37019 Peschiera del Garda, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elisa","family":"Damiani","sequence":"additional","affiliation":[{"name":"Thoracic Oncology\u2014Lung Unit, Pederzoli P. Hospital, 37019 Peschiera del Garda, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Santo","sequence":"additional","affiliation":[{"name":"Thoracic Oncology\u2014Lung Unit, Pederzoli P. Hospital, 37019 Peschiera del Garda, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Filho","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Li, P., Wang, D., Yang, X., Liu, C., Li, X., Zhang, X., Liu, K., Zhang, Y., Zhang, M., and Wang, C. (2024). Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification. Molecules, 29.","DOI":"10.3390\/molecules29081901"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.trecan.2024.07.008","article-title":"Small cell lung cancer profiling: An updated synthesis of subtypes, vulnerabilities, and plasticity","volume":"10","author":"Redin","year":"2024","journal-title":"Trends Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1183\/13993003.00359-2016","article-title":"Risk factors for lung cancer worldwide","volume":"48","author":"Malhotra","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"189166","DOI":"10.1016\/j.bbcan.2024.189166","article-title":"Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy","volume":"1879","author":"Jia","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1186\/s12967-025-07207-6","article-title":"Integrated multi-omics reveals glycolytic gene signatures of lung adenocarcinoma brain metastasis and the impact of Rac2 lactylation on immunosuppressive microenvironment","volume":"23","author":"Yi","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ejca.2010.01.012","article-title":"EORTC Quality of Life Group, and Brain Cancer, NCIC and Radiotherapy Groups. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients","volume":"46","author":"Taphoorn","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4161\/cbt.2.5.452","article-title":"Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line","volume":"2","author":"Qi","year":"2003","journal-title":"Cancer Biol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1158\/0008-5472.CAN-07-0407","article-title":"Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin","volume":"67","author":"Son","year":"2007","journal-title":"Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"13279","DOI":"10.1021\/bi9828674","article-title":"Ca2+-induced increased lipid packing and domain formation in submitochondrial particles. A possible early step in the mechanism of Ca2+-stimulated generation of reactive oxygen species by the respiratory chain","volume":"38","author":"Grijalba","year":"1999","journal-title":"Biochemistry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.1471-4159.1994.63020584.x","article-title":"Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated CA2+ and Na+: Implications for neurodegeneration","volume":"63","author":"Dykens","year":"1994","journal-title":"J. Neurochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11010-019-03640-6","article-title":"Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion","volume":"463","author":"Si","year":"2020","journal-title":"Mol. Cell Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hung, C.M., Wu, C.T., Jain, S., and Wu, C.E. (2024). Utilizing Plasma-Based Next-Generation Sequencing to Expedite the Diagnostic Process in Suspected Lung Cancer: A Case Report. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158124"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.18632\/oncotarget.28587","article-title":"The importance of integrated therapies on cancer: Silibinin, an old and new molecule","volume":"15","author":"Roca","year":"2024","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.HNP.0000334924.77174.6d","article-title":"Milk thistle (Silybum marianum): An ancient botanical medicine for modern times","volume":"22","author":"Ross","year":"2008","journal-title":"Holist. Nurs. Pract."},{"key":"ref_17","first-page":"308","article-title":"\u201cSilymarin\u201d, a promising pharmacological agent for treatment of diseases","volume":"14","author":"Karimi","year":"2011","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_18","first-page":"410","article-title":"A review of plants used in the treatment of liver disease: Part 1","volume":"3","author":"Luper","year":"1998","journal-title":"Altern. Med. Rev. J. Clin. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1021\/jo302720h","article-title":"HiFSA fingerprinting applied to isomers with near-identical NMR spectra: The silybin\/isosilybin case","volume":"78","author":"Napolitano","year":"2013","journal-title":"J. Org. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Bijak, M., Synowiec, E., Sitarek, P., Sliwi\u0144ski, T., and Saluk-Bijak, J. (2017). Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models. Nutrients, 9.","DOI":"10.3390\/nu9121356"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/ptr.3207","article-title":"Milk thistle in liver diseases: Past, present, future","volume":"24","author":"Abenavoli","year":"2010","journal-title":"Phytother. Res. PTR"},{"key":"ref_22","first-page":"511","article-title":"A Review of Herbal and Pharmaceutical Galactagogues for Breast-Feeding","volume":"16","author":"Bazzano","year":"2016","journal-title":"Ochsner J."},{"key":"ref_23","first-page":"839","article-title":"Silymarin BIO-C, an extract from Silybum marianum fruits, induces hyperprolactinemia in intact female rats","volume":"16","author":"Capasso","year":"2009","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/med.20115","article-title":"Recent advances in plant hepatoprotectives: A chemical and biological profile of some important leads","volume":"28","author":"Negi","year":"2008","journal-title":"Med. Res. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctrv.2017.06.003","article-title":"Targeting STAT3 with silibinin to improve cancer therapeutics","volume":"58","author":"Queralt","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"ref_26","first-page":"2649","article-title":"Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells","volume":"23","author":"Sharma","year":"2003","journal-title":"Anticancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ray, P.P., Islam, M.A., Islam, M.S., Han, A., Geng, P., Aziz, M.A., and Al Mamun, A. (2024). A comprehensive evaluation of the therapeutic potential of silibinin: A ray of hope in cancer treatment. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1349745"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00435979","article-title":"The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer specific questionnaires","volume":"5","author":"Osoba","year":"1996","journal-title":"Qual. Life Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: An accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"153598","DOI":"10.1016\/j.tox.2023.153598","article-title":"Silibinin exerts neuroprotective effects against cerebral hypoxia\/reoxygenation injury by activating the GAS6\/Axl pathway","volume":"495","author":"Weiping","year":"2023","journal-title":"Toxicology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"154594","DOI":"10.1016\/j.phymed.2022.154594","article-title":"Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer\u2019s disease models","volume":"109","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"109691","DOI":"10.1016\/j.abb.2023.109691","article-title":"Silibinin ameliorates STING-mediated neuroinflammation via downregulation of ferroptotic damage in a sporadic Alzheimer\u2019s disease model","volume":"744","author":"Liu","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"14769","DOI":"10.1038\/s41598-024-65881-w","article-title":"The silibinin-loaded Zein-\u03b2 cyclodextrin nano-carriers (SZBC-NCs) as a novel selective cancer cell drug delivery system in HT-29 cell line","volume":"14","author":"Goodarzi","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2174\/0118715206295371240724092314","article-title":"Silibinin Induces Both Apoptosis and Necroptosis with Potential Anti-tumor Efficacy in Lung Cancer","volume":"24","author":"Zhang","year":"2024","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_35","first-page":"90","article-title":"Using the Common Terminology Criteria for Adverse Events (CTCAE\u2014Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies","volume":"112","author":"Santana","year":"2021","journal-title":"Actas Dermo-Sifiliogr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: The current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"},{"key":"ref_38","first-page":"5617","article-title":"Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells","volume":"60","author":"Zi","year":"2000","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.onc.1205240","article-title":"Silibinin inhibits constitutive and TNF\u03b1-induced activation of NF-\u03baB and sensitizes human prostate carcinoma DU145 cells to TNF\u03b1-induced apoptosis","volume":"21","author":"Dhanalakshmi","year":"2002","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1158\/0008-5472.CAN-07-6247","article-title":"Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis","volume":"68","author":"Singh","year":"2008","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s11064-009-9935-6","article-title":"Silibinin inhibits glioma cell proliferation via Ca2+\/ROS\/MAPK-dependent mechanism in vitro and glioma tumor growth in vivo","volume":"34","author":"Kim","year":"2009","journal-title":"Neurochem. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s10495-015-1198-x","article-title":"Anti-tumor activities of luteolin and silibinin in glioblastoma cells: Overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo","volume":"21","author":"Chakrabarti","year":"2016","journal-title":"Apoptosis"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nm.2072","article-title":"Real-time imaging reveals the single steps of brain metastasis formation","volume":"16","author":"Kienast","year":"2010","journal-title":"Nat. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","article-title":"Serpins promote cancer cell survival and vascular co-option in brain metastasis","volume":"156","author":"Valiente","year":"2014","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature18268","article-title":"Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer","volume":"533","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"106311","DOI":"10.1016\/j.phrs.2022.106311","article-title":"STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response","volume":"182","author":"Sadrkhanloo","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"27461","DOI":"10.18632\/oncotarget.4742","article-title":"STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation","volume":"6","author":"Singh","year":"2015","journal-title":"Oncotarget"},{"key":"ref_48","unstructured":"(2024, August 25). Stat3 Orchestrates Interaction Between Endothelial and Tumor Cells and Inhibition of Stat3 Suppresses Brain Metastasis of Breast Cancer Cells\u2014PubMed. Available online: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy.unibs.it\/25881542\/."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.18632\/oncotarget.475","article-title":"The expression of p-STAT3 in stage IV melanoma: Risk of CNS metastasis and survival","volume":"3","author":"Lee","year":"2012","journal-title":"Oncotarget"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1080\/17512433.2016.1208563","article-title":"Silibinin: A potential old drug for cancer therapy","volume":"9","author":"Zhu","year":"2016","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_51","unstructured":"Di Pierro, F., Callegari, A., Carotenuto, D., and Tapia, M.M. (2024, August 25). Clinical Efficacy, Safety and Tolerability of BIO-C (Micronized Silymarin) as a Galactagogue\u2014PubMed. Available online: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy.unibs.it\/19260380\/."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fct.2013.02.023","article-title":"Biosafety and antioxidant effects of a beverage containing silymarin and arginine. A pilot, human intervention cross-over trial","volume":"56","author":"Vacek","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1124\/dmd.114.057232","article-title":"The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity","volume":"42","author":"Frye","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"ref_54","first-page":"OC11","article-title":"Effect of silymarin in the prevention of Cisplatin nephrotoxicity, a clinical trial study","volume":"9","author":"Momeni","year":"2015","journal-title":"J. Clin. Diagn. Res. JCDR"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ptr.5345","article-title":"Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial","volume":"29","author":"Shahbazi","year":"2015","journal-title":"Phytother. Res. PTR"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/ijc.22465","article-title":"Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells","volume":"120","author":"Flaig","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/ptr.5704","article-title":"Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial","volume":"30","author":"Elyasi","year":"2016","journal-title":"Phytother. Res. PTR"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5507\/bp.2010.036","article-title":"The safety and efficacy of a silymarin and selenium combination in men after radical prostatectomy\u2014A six month placebo-controlled double-blind clinical trial","volume":"154","author":"Vidlar","year":"2010","journal-title":"Biomed. Pap."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"68305","DOI":"10.18632\/oncotarget.20054","article-title":"Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer","volume":"8","author":"Belli","year":"2017","journal-title":"Oncotarget"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/h0074329","article-title":"The graphic rating scale","volume":"14","author":"Freyd","year":"1923","journal-title":"J. Educ. Psychol."}],"container-title":["NeuroSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2673-4087\/6\/4\/131\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:03:52Z","timestamp":1766052232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2673-4087\/6\/4\/131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["neurosci6040131"],"URL":"https:\/\/doi.org\/10.3390\/neurosci6040131","relation":{},"ISSN":["2673-4087"],"issn-type":[{"type":"electronic","value":"2673-4087"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}